Updated May. 10, 2011 at 7:33 a.m.

Premium Lock Inspire reports $17.6M quarterly loss after restructuring

Published: 2011-05-10 07:31:00
Updated: 2011-05-10 07:33:08

Print this blog post
Inspire eye drug fails Phase II trials Inspire drug fails Phase II trials Image 1 of 2 · Next Image…

The Raleigh-based pharmaceutical firm, which is in the process of being acquired by drug giant Merck, says losses increased nearly $3 million from a year ago....

Read More
Read More

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll